Patents

Partner Content

Partner Content

Exclusive Interview with ASBM Released Ahead of Upcoming Bio...

SMi Reports: Interview with expert speaker from Alliance for Safe Biologic Medicines (ASBM) released for the 2019 Biosimilars conference

News

UK pharma patents up 20%, new report finds

The pharma industry saw double-digit growth in patent filings for the second year in a row in 2018, with applications from the UK up by a fifth, according to the latest

News

Teva and Neos settle over Cotempla patent dispute

Teva and Neos Therapeutics have reached a confidential settlement and licensing agreement that resolves a patent dispute over the Israeli firm's generic version of Neos’ ADHD drug Cotempla XR-OD

Views & Analysis

Will plausibility reign supreme in Lyrica second medical use...

Pharma needs clarity from the Supreme Court on whether the whole scope of a patent claim must be plausible at the time of the application.

Views & Analysis

Local partnerships key to pharma’s success in China

China has become more accepting of Western medicines and sees the value of a strong patenting process, opening the door for more foreign trade and mutual benefits.

News